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Young onset Alzheimer’s disease (YOAD) is defined as symptom onset before the age of 
65 years and is particularly associated with phenotypic heterogeneity. Atypical presen-
tations, such as the clinic-radiological visual syndrome posterior cortical atrophy (PCA), 
often lead to delays in accurate diagnosis. Eyetracking has been used to demonstrate 
basic oculomotor impairments in individuals with dementia. In the present study, we 
aim to explore the relationship between eyetracking metrics and standard tests of visual 
cognition in individuals with YOAD. Fifty-seven participants were included: 36 individuals 
with YOAD (n =  26 typical AD; n =  10 PCA) and 21 age-matched healthy controls. 
Participants completed three eyetracking experiments: fixation, pro-saccade, and 
smooth pursuit tasks. Summary metrics were used as outcome measures and their 
predictive value explored looking at correlations with visuoperceptual and visuospatial 
metrics. Significant correlations between eyetracking metrics and standard visual cogni-
tive estimates are reported. A machine-learning approach using a classification method 
based on the smooth pursuit raw eyetracking data discriminates with approximately 
95% accuracy patients and controls in cross-validation tests. Results suggest that the 
eyetracking paradigms of a relatively simple and specific nature provide measures not 
only reflecting basic oculomotor characteristics but also predicting higher order visuo-
spatial and visuoperceptual impairments. Eyetracking measures can represent extremely 
useful markers during the diagnostic phase and may be exploited as potential outcome 
measures for clinical trials.
Keywords: young onset alzheimer’s disease, eye movements, eyetracking metrics, cognitive visual functions, 
machine learning, classification model
inTrODUcTiOn
Alzheimer’s disease (AD) is the most common major neurodegenerative dementia type (1). While 
characterized by gradual and progressive episodic memory impairment, it is also associated with 
other cognitive impairments such as executive dysfunction, language, praxis, and complex visual 
processing deficits (2–5). Several phase three clinical trials have recently failed and there are no 
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disease-modifying treatments available for AD (6, 7). Sensitive 
and sensible markers are needed to facilitate earlier diagnosis and 
to serve as outcome measures in clinical trials.
The focus of neuropsychological investigations in AD has 
previously been directed toward the study of anterograde 
episodic memory, and attentional and executive processes as 
primary consequences of AD and sources of functional impair-
ment (8); by contrast, cognitive visual impairment has been 
widely overlooked (9). More recently, the presence of both low 
and high-level visual processing impairments has received more 
attention [for a review see Ref. (10)]. Deficits related to both 
the ventral and dorsal processing pathways have been described; 
impairments in object and facial recognition and color and 
pattern processing have been reported (11–13); abnormal 
performance has also been shown for tasks investigating visuos-
patial processing and motion perception (13–15). The presence 
of visual impairments has been associated with the severity of 
the disease (11, 13, 16, 17), leading to the possibility that visual 
testing could provide a method of screening and tracking AD. 
Studies suggest that cognitive visual deficits are more marked in 
young vs. late onset AD (18) and there may also be qualitative 
differences in the nature of the deficits. While some studies have 
highlighted the prominence of both ventral and dorsal stream 
deficits in late onset AD (13, 19), disproportionately impaired 
visuospatial ability has been described in young onset AD (18). 
Furthermore, the so called “visual variant” of AD—posterior 
cortical atrophy (PCA)—in which visual symptoms predominate 
(20–23) exhibits commonalities in cortical thinning with typical, 
amnestic AD particularly within temporoparietal regions (24), 
suggesting a continuum of visual impairment between typical 
AD (tAD) and PCA.
Posterior cortical atrophy is a progressive neurodegenerative 
syndrome mainly caused by AD pathology and characterized 
by progressive visuospatial and visuoperceptual dysfunction 
with relatively preserved memory, insight, and judgment (20). 
Individuals with PCA often manifest some or all of the features 
of Balint’s syndrome such as simultanagnosia, oculomotor 
apraxia, optic ataxia, and environmental agnosia (21–23, 25–28). 
Not only differences but also similarities have been described 
between PCA and tAD in terms of visual processing deficits (29), 
emphasizing the need for further study on the cognitive visual 
deficits in AD.
Recently, eyetracking technology has become more widely 
available and the simplicity of the instruments needed to collect 
good quality eyetracking data has enabled the application of the 
methodology to clinical populations (29–32). The resulting litera-
ture has demonstrated the presence of oculomotor impairment in 
AD patients as compared to age-matched healthy controls: longer 
saccade latencies in pro-saccade tasks and lower accuracy than 
controls in anti-saccade tasks have been reported in AD (33–37), 
together with abnormalities in saccadic accuracy (38–41).
The study by Shakespeare et al. (29) represents, to our knowl-
edge, the only direct comparison between the basic oculomo-
tor characteristics of individuals with PCA, tAD, and healthy 
controls. PCA patients showed increased time to saccadic target 
fixation, increased first major saccade latency, and decreased 
saccadic amplitude as compared to both tAD and controls. The 
patients with PCA also showed more frequent large intrusive 
saccades and lower longest period of fixation in the fixation 
stability task and lower pursuit and more saccades per trial in 
the smooth pursuit task as compared to controls. The authors 
also described impaired performance in the fixation stability test 
in tAD patients, who produced a large proportion of square wave 
jerks as compared to controls and individuals with PCA. As in 
PCA, tAD patients also had shorter maximum fixation period 
than the healthy controls. In the smooth pursuit task, both 
PCA and tAD patients showed significantly lower gain than the 
control group (29).
In cognitive psychology, eyetracking metrics have frequently 
been used to study higher order cognitive functions (42, 43). 
However, few studies in the field of dementia have utilized this 
potential to date. Crutcher and colleagues (44) and Richmond 
and colleagues (45) used a visual paired-comparison task and 
showed that eye movement metrics, such as number of fixations 
and fixation duration, can be indicative of short-term memory 
difficulties in a group of patients with mild cognitive impairment 
(MCI) as compared to age-matched controls. Fernández et al. (46) 
have investigated the semantic, working, and retrieval memory 
deficits in individuals with young onset AD by looking at differ-
ences with controls when reading high- and low-predictability 
sentences.
Despite the above-reported evidence of visual cognitive 
processing impairments and oculomotor deficits in both AD and 
PCA, little has been done so far to exploit eyetracking metrics as 
a route to explore deficits in visual cognition.
There are multiple potential advantages of using eyetracking 
metrics for studying visual cognitive processing in dementia. In 
contrast to many traditional neuropsychological assessments, 
eye movement recording does not require additional behavioral 
responses, such as button presses or verbal responses to make 
inferences about psychological changes. Eyetracking is also 
non-invasive and does not have contraindications, making it 
particularly well suited for patient studies. Moreover, modern 
eyetracking systems have excellent recording frames of up to 
1,000  Hz, enabling the building of very large datasets (time 
series of x and y coordinates) in a relatively short amount of time 
(e.g., a 1,000 Hz system generates 600,000 x–y data coordinates 
for a 10-min recording session). Such qualities represent incen-
tives to fully explore the possible contribution of eyetracking 
metrics to an accurate and sensitive diagnosis and as outcome 
markers for clinical trials. An increasingly practical approach to 
take advantage of the volume of eyetracking datasets involves the 
application of machine-learning methods, in which automati-
cally generated feature vectors of individual participants may be 
used to assign categories to each participant.
In the present study, we explored the relationship between 
eyetracking and standard visual cognitive tests in individu-
als with young onset AD (both tAD and PCA). We extracted 
standard eyetracking summary metrics and used them to test 
the hypothesis according to which such metrics well correlate 
with visuoperceptual and visuospatial metrics derived from 
standard cognitive tests. We then applied a machine-learning 
approach to a proportion of the data to explore the possibility 
of automatically discriminating patients and healthy individuals 
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on the basis of raw eyetracking metrics only (i.e., time series of 
x and y coordinates). Therefore, our secondary hypothesis was 
that machine-learning classifiers would offer the discriminative 
power (47) for the diagnosis of young onset AD among healthy 
controls based on oculomotor profiles during a discrete task.
MaTerials anD MeThODs
Participants
The study was approved by the local Research Ethics Committee 
and all participants provided written informed consent according 
to guidelines established by the Declaration of Helsinki.
Data were collected from 36 individuals with young onset 
Alzheimer’s disease (YOAD) (26 patients with tAD and 10 
patients with PCA) and 21 age-matched healthy controls. Patients 
with PCA fulfilled standard criteria for PCA (21, 22). Patients 
with AD had a clinical diagnosis of probable AD and fulfilled 
the NIA (National Institute of Aging) clinical criteria (5). Healthy 
controls and patients with YOAD did not differ in terms of age 
at assessment (two sample t-test, t = 0.09, p = 0.93) or years of 
education (Wilcoxon Mann–Whitney U-test, z = 1.57, p = 0.12) 
(Table 1). Healthy controls and YOAD patients differed in terms 
of Mini-Mental State Examination (MMSE) scores (Wilcoxon 
Mann–Whitney U-test, z = 6.21, p < 0.0001). Within the YOAD 
patients, tAD and PCA were matched in terms of disease dura-
tion [tAD: 5.0 (2.8) years and PCA: 5.6 (3.4) years, Wilcoxon 
Mann–Whitney U-test, z = −0.50, p = 0.62] and MMSE scores 
[tAD: 20.1 (0.8) and PCA: 23.1 (1.5), Wilcoxon Mann–Whitney 
U-test, z = −1.78, p = 0.07].
All participants had a detailed neuropsychology assessment 
investigating memory, language, executive function, and vision. 
The battery included six standard visual tasks, which were the 
focus of the subsequent correlational analysis between eyetrack-
ing and traditional neuropsychological metrics. Early visual 
processing was examined using the shape detection subtest from 
the Visual and Object Space Perception battery (VOSP) (48) 
where individuals were presented with 20 patterns, 11 of which 
contained a faint cross. Participants were asked to express a judg-
ment as to whether a faint cross was present or not with score 
ranging from 10 (chance) to 20. Visuoperceptual processing was 
assessed using the fragmented letters and object decision VOSP 
subtests (48). In the former, individuals were asked to identify 
20-fragmented capital letters presented one at a time with score 
ranging from 0 to 20. In the latter, they were asked to identify, 
among four silhouettes, which one represented a real life object 
[score ranged from 5 (chance) to 20]. Visuospatial processing 
was assessed using the dot-counting VOSP subtest (48) and letter 
cancelation test (49). In the dot-counting test, individuals were 
presented with 10 pages containing from 5 to 9 dots in different 
positions and asked to identify the number of dots without using 
their fingers (score range: 0–10). In the “A” cancelation task, 
participants were presented with an A4 sheet and asked to mark 
all the letters “A” embedded among 69 distractors (other letters) 
within 90 s. Last, single word recognition was assessed using the 
National Adult Reading Test (NART) (50) where individuals were 
asked to read 50 words aloud (score ranged from 0 to 50).
equipment
The experiment was run on a Dell 2120 desktop computer with 
a 23-inch screen at a viewing distance of 60  cm. Eye move-
ments were recorded at 250 Hz using a head-mounted infrared 
video-based eye tracker (Eyelink II; SR Research). A chin rest 
was used to provide stability and maintain the viewing distance. 
The Eyelink system considered saccades using standard velocity 
and acceleration thresholds (30°/s and 8,000°/s2) and automati-
cally identified periods with no saccadic movement as fixations. 
A 9-point calibration and validation were performed prior to 
each experiment. All the data were obtained from recordings 
with an average Cartesian prediction error of <1° during the 
validation. A drift correction procedure was used before each 
individual trial.
Procedure
Three eyetracking experiments were performed:
Fixation stability: a red cross subtending at 0.5° of visual angle 
was presented in the center of the screen for 10 s. There was 
a practice trial followed by three test trials and participants 
were instructed to “look as closely as possible at the red cross 
without blinking for 10 s” (29, 51).
Pro-saccade: participants were initially presented with a black cir-
cle (subtending 0.4° of visual angle) having a white inner circle 
(0.1°) in the center of the screen lasting 500 ms. A blank screen 
was then displayed for 200 ms. After this, a target (black circle 
having a diameter of 0.75° and an inner white circle subtend-
ing 0.25°) was shown. The target remained on the screen until 
a fixation of minimum 250 ms duration was made within an 
area of 1.5° of visual angle from the center of the target (interest 
area) or after 5,000 ms from target onset. The participant’s task 
was to look at the target as quickly and accurately as possible 
when it appeared. The target appeared in one of 10 possible 
locations: 5°, 10°, or 15° either on the left or on the right, 5° or 
10° either up or down. There were four trials for each location, 
giving a total of 40 test trials. Trials were split into two blocks 
(n = 20 each) with target locations randomized and balanced 
within each block. Four practice trials were used. The target 
positions were pseudo-randomized but their order was kept 
constant for all participants.
Smooth pursuit: the target was a red circle subtending 0.5° of 
visual angle in diameter. Twelve trials of target sinusoidal 
movement followed (horizontal: n = 6; vertical: n = 6). Two 
target velocities were used (10° and 20° of visual angle/second). 
The frequency of the target oscillation was set at 0.25 Hz for 
a target speed of 10°/s and 0.5 Hz for a target speed of 20°/s. 
Each trial lasted 10 s. The task started with two practice trials. 
Participants were instructed to follow the target as closely as 
possible with their eyes.
eyetracking summary Metrics
All eyetracking recordings were visually inspected using Data 
Viewer and trials and/or participants were excluded if there was 
a significant signal loss that would have interfered with the data 
analysis and interpretation of results. Overall, 5.4% of the trials 
TaBle 1 | Mean and SD demographic information and neuropsychology scores for the 36 patients with young onset Alzheimer’s disease (YOAD) and 21 age-matched 
healthy controls.
Max score controls (N = 21) YOaD (N = 36) N (%) below 5%a normative mean (sD)
Demographics
Gender M:F 11:10 17:19 NA NA
Age (years) 61.0 (5.3) 60.9 (5.2) NA NA
Education (years) 16.5 (3.2) 15.3 (2.7) NA NA
Disease duration (years) NA 5.2 (2.9) NA NA
Background neuropsychology
MMSE 30 29.5 (0.7) 20.9 (4.4) NA 29.0 (1.3)
Visual acuity: Snellenb 6/9 NA 6/9 NA NA
WASI vocabulary 80 69.0 (8.5) 53.4 (18.3) 1 (2.8%) NA
WASI matrices 32 26.7 (2.7) 8.1 (7.1) 8 (22.2%) NA
Digit span forward (max) 8 7.3 (1.2) 5.4 (1.5) 11 (30.6%) NA
Digit span backward (max) 7 5.4 (0.9) 3.2 (1.5) 10 (27.8%) NA
RMT for faces 25 24.7 (0.8) 19.5 (4.4) 11 (30.6%) 22.8 (1.9)
RMT for words 25 24.4 (1.4) 17.5 (3.2) 27 (75.0%) 23.7 (1.8)
GDA: oral 24 13.8 (6.6) 2.9 (4.7) 25 (69.4%) 11.95 (5.1)
early visual processing
Shape detection (VOSP) 20 19.5 (0.8) 18.0 (1.4) NA 19.5 (0.7)
Visuoperceptual processing
Object decision (VOSP) 20 18.2 (1.4) 14.7 (3.9) 12 (33.3%) 17.7 (1.9)
Fragmented letters (VOSP) 20 19.5 (0.7) 11.2 (7.2) 23 (63.9%) 18.8 (1.4)
Visuospatial processing
Dot counting: n correct 10 9.9 (0.3) 7.6 (2.9) 16 (44.4%) 9.9 (0.2)
A cancelation time (s) 90 21.1 (6.0) 54.0 (22.8) 27 (75.0%) 20.5 (6.5)
Word recognition
NART: number of errors 50 11.5 (8.0) 20.1 (11.0) NA NA
Mini-Mental State Examination (MMSE) (67); Cortical Vision Screening Test (CORVIST) (68); Wechsler Abbreviated Scale of Intelligence (WASI) (69); Wechsler Memory Scale Revised-
digit span forwards and backwards (70); Matrices and Vocabulary subtest; Short Recognition Memory Test (RMT) for words and faces (71); oral Graded Difficulty Arithmetic (GDA) 
subtests addition and subtraction (72); Visual Object and Space Perception battery subtest object decision, shape detection, fragmented letters and dot counting (48); A cancelation 
(49); National Adult Reading Test (NART) (50). NA, not available.
aPercentage of scores below 5% percentile are shown for the YOAD group (the performance of controls did not reach this level).
bMedian value is reported.
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were excluded from the fixation stability task, 3.6% from the 
pro-saccade and 4% from the smooth pursuit tasks.
Blinks were identified and removed using Eyelink’s automated 
blink detection and practice trials were discarded from the 
analysis. Vision was binocular but eye movements from the right 
eye were recorded. If a problem was detected (i.e., poor eyesight, 
watery, or dry eye) recordings were performed using the left eye.
Statistical analyses were carried out using Stata (v. 12.1).
Fixation Stability
All participants performed the fixation stability task but two 
controls were excluded from analysis because of failure in signal 
detection. The relevant eyetracking metrics for the fixation sta-
bility task were large intrusive saccades, square wave jerks, and 
maximum fixation duration (29).
Number of Large Intrusive Saccades
The number of saccades with an amplitude greater than 2° of 
visual angle were identified as large intrusive saccades (29, 35).
Number of Square Wave Jerks
Square wave jerks were identified as saccades smaller than 2° in 
amplitude which took the gaze away from the target position, 
were followed within 300 ms by another saccade with a similar 
amplitude (difference in amplitude <0.75°) and took the gaze 
back to the target position (29, 52).
Maximum Fixation Duration
The longest period of fixation on the target (length of time 
between saccades) was measured for each participant (29, 35).
Pro-Saccade
All participants performed the pro-saccade task but two indivi d uals 
(a YOAD patient and a control) were excluded from the analysis 
due to a failure in signal detection. For this task, the following vari-
ables were taken into account: accuracy, time to fixate the target, 
and number of saccades necessary to fixate the target. For these 
metrics, fixations made within an area of 1.5° from the center of 
the target (interest area) were considered to have met the target.
Accuracy
This metric was defined as the ability of the participant to fixate 
the target (within 1.5° from its center) while it was presented 
on the screen.
Time to Fixate the Target
The time between the target onset and the first fixation reaching 
the target was calculated. Negative values due to anticipatory 
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saccades were either corrected if another fixation reaching the 
interest area was detected (0.09%) or removed if no fixation 
reached the interest area after target onset (0.14%).
Number of Saccades Necessary to Fixate the Target
The minimum number of saccades necessary to fixate the target 
was calculated for each trial.
Smooth Pursuit Task
All but three patients performed the smooth pursuit task. 
A control and a patient were excluded from the analysis due to a 
signal failure. The following variables were extracted: pursuit gain 
and proportion of time pursuing the target.
Pursuit Gain
This was defined by the ratio between the eye and the target 
velocity (in the relevant direction). Saccades and blinks were 
excluded and only a ratio greater than 0.5 was considered as 
pursuit gain. This cut-off was applied to dismiss eye movements 
happening after anticipatory saccades and turnaround points in 
each trial.
Proportion of Time Pursuing the Target
The proportion of time the participant spent pursuing the target 
during the trial was reported. This was calculated taking into 
account the number of samples considered as pursuit gain and 
multiplying this value by four (recordings were made at 250 Hz).
statistical analysis
Differences in eyetracking metrics between the YOAD group and 
healthy controls were evaluated using linear regression models 
(clustered by participants) with robust SEs adjusted for repeated 
measures. Gender and age were considered as covariates for all 
metrics and stimulus distance and direction were considered as 
additional covariates for the pro-saccade task as well as target 
direction and velocity for the smooth pursuit task.
Normal distribution was assessed using the Shapiro–Wilk 
normality test. As the data were not normally distributed, a 
non-parametric measure of correlation (Spearman’s correlations) 
was performed and the coefficients reported. Correlations were 
explored between all oculomotor metrics and six standard visual 
cognitive tests including measures of early visual processing 
(shape detection); visuoperceptual processing (fragmented let-
ters and object decision); visuospatial processing (dot counting 
and “A” cancelation); and single word recognition tests (NART).
Machine learning classification Model
A machine-learning classification model is presented here as a 
proof of concept. As the statistical model aims to model move-
ments in gaze location, the smooth pursuit experiment provided 
the most suitable data. The fixation stability and saccade experi-
ments are designed to elicit 0 and one-gaze movements, respec-
tively, and as such, their data did not provide enough information 
to discriminate between diagnostic classes on the basis of gaze 
movements. For this reason, the data from the smooth pursuit 
task were used in the pilot automatic classification procedure for 
the present study.
The automated classification procedure used the eyetracking 
data from the smooth pursuit task and modeled the movements 
in gaze location as the target moved. The gaze movements of 
each individual were used along with the statistical model to 
automatically generate feature vectors. These feature vectors 
were then used in a classification procedure that could predict 
the diagnoses of unseen individuals. The procedure, therefore, 
consisted of three components: (a) a fitted statistical model of 
each individual’s data, (b) the generation of feature vectors for 
each individual via the fitted model, and (c) the classification of 
individuals via their feature vectors.
A hidden Markov model (HMM) (53) was the statistical 
model used. This considers movements in gaze location, and 
assumes that each gaze movement has an underlying “intended” 
movement direction. We have assumed that each gaze move-
ment was a noisy application of one of the following possibilities: 
“no movement,” “left,” “right,” “up,” or “down.” The HMM is 
slightly non-standard, in that fixed transformations of each gaze 
movement are applied before they are passed to the sub-model 
associated with each underlying intended movement direction. 
Furthermore, knowledge of where the gaze “should” be moving 
to was incorporated via the location of the target at each time. 
Intended movement directions that were more aligned to the 
target direction were given a higher likelihood. This implemented 
the natural assumption that individuals would follow the target as 
long as they were able to.
If Y1:T denotes the gaze movements for an individual over 
the course of one trial, U1:T denotes the direction of the target 
from the current gaze location at each time, and X1:T denotes 
the (unknown) underlying intended movement directions, 
then
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where Yt Xt( )  are the transformed data and θ µ pi= ( )ΣX Xt t P, , ,1  
are the parameters of the model. N(|μ,Σ) indicates the normal 
distribution with mean μ and covariance matrix Σ, and f(Ut ⃒Xt) 
are parameter-free logarithmic distributions that go to 0 as the 
target direction diverges from the intended direction Xt.
The model could be fit to the data using the EM algorithm 
(54). For every trial in the experiment, we fit the model to the 
data for one control. The individual that could follow the dot 
most accurately was subjectively chosen.
Once a model for each trial in the smooth pursuit experiment 
had been fitted, this could be used to generate feature vectors for 
each individual. The feature vectors are composites, made as the 
sum of “Fisher” feature vectors from the fitted models for each 
trial. Fisher feature vectors were computed as the gradient vectors 
of the data log-likelihood, evaluated at the fitted parameter set-
tings. If Z(j) is the Fisher feature vector for an individual in trial j, 
Y1:T are the gaze movement data for that trial, and θ
^ is the fitted 
parameter vector, then
 Z Pr Yj T( ) ∇ ( θ)= =θ θ θlog | |:1   (2)
TaBle 2 | Mean and SD of fixation stability, pro-saccade, and smooth pursuit 
metrics for young onset Alzheimer’s disease (YOAD) patients and age-matched 
healthy controls.
YOaD controls
Mean (sD) Mean (sD)
Fixation stability
Number of large 
intrusive saccades
2.5 (4.3)* 0.7 (1.7)*
Number of square wave 
jerks
0.9 (1.6) 0.9 (1.6)
Maximum fixation 
duration (ms)
1,950.7 (1,352.8)* 2,908.5 (2,062.1)*
Pro-saccade
Accuracy Overall 0.85 (0.35)* 0.94 (0.24)*
5° 0.90 (0.31) 0.96 (0.19)
10° 0.84 (0.37)* 0.92 (0.27)*
15° 0.81 (0.39)* 0.93 (0.26)*
Up 0.86 (0.35) 0.90 (0.30)
Down 0.86 (0.32)* 0.93 (0.22)*
Right 0.83 (0.38)* 0.97 (0.18)*
Left 0.86 (0.35) 0.93 (0.25)
Time taken to reach the 
target (ms)
Overall 538.7 (682.3)* 328.7 (329.8)*
5° 437.1 (583.0)* 306.1 (366.6)*
10° 613.8 (777.3)* 337.4 (333.4)*
15° 609.0 (650.4)* 358.8 (222.9)*
Up 537.8 (648.5)* 365.6 (468.4)*
Down 518.5 (571.2)* 329.2 (163.4)*
Right 591.0 (827.1)* 300.6 (180.7)*
Left 501.9 (613.8)* 333.6 (413.8)*
Saccades made to 
reach the target
Overall 3.1 (2.3)* 2.1 (1.2)*
5° 2.7 (1.9)* 2.0 (1.2)*
10° 3.4 (2.7)* 2.1 (1.1)*
15° 3.4 (2.4)* 2.2 (1.2)*
Up 3.3 (2.4)* 2.3 (1.3)*
Down 3.1 (2.5)* 2.1 (1.1)*
Right 3.0 (2.1)* 2.1 (1.2)*
Left 3.0 (2.2)* 2.0 (1.1)*
smooth pursuit
Pursuit gain Overall 1.4 (0.4) 1.4 (0.4)
10°/s 1.4 (0.3) 1.4 (0.4)
20°/s 1.3 (0.4) 1.4 (0.4)
Horizontal 1.3 (0.3) 1.3 (0.3)
Vertical 1.5 (0.4) 1.4 (0.4)
Prop. of time pursuing 
the target
Overall 0.4 (0.2)* 0.6 (0.2)*
10°/s 0.5 (0.2)* 0.6 (0.1)*
20°/s 0.3 (0.2)* 0.5 (0.2)*
Horizontal 0.5 (0.2)* 0.7 (0.1)*
Vertical 0.3 (0.1)* 0.5 (0.1)*
Statistically significant differences are highlighted in blue and marked with an asterisk (*) 
(for specific p values see text).
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which is a vector with as many dimensions as the model has 
parameters. The sum over trials gave the un-normalized feature 
vectors for each individual:
 
Z Z
j
j^ =∑ ( )
 
(3)
Once all un-normalized feature vectors for an experiment had 
been computed, they were normalized element-wise by their SDs 
(over individuals):
 
Z Z
std Z
i
i
t
=
^
^{ }  
(4)
where Zi and Zi are the ith elements of the normalized and un-
normalized feature vectors, respectively.
These feature vectors can be used in many classification algo-
rithms. We chose to use logistic regression to classify individuals. 
As there are approximately as many individuals in the dataset as 
there are dimensions to the feature vectors, the logistic regression 
classifier required some regularization. We used the Bayesian 
methodology to regularize the classifier, placing a sparsity prior 
on the weights in the classifier. If d(Z) is the diagnosis of the 
patient associated with feature vector Z (with 0 meaning control 
and 1 meaning either tAD or PCA), and w are the weights of the 
model, then
 
Pr d Z w Zw
Pr w N w
i
i i
( ( ) ) σ( )
( ) ( )∏
= =
= −
1
0 1
|
| | ,α α  (5)
where σ() is the sigmoid function, and α are the Bayesian hyper-
parameters of the model.
The performance of the classifier was assessed through cross-
validation tests. Leave-one-out, leave-two-out, and leave-half-out 
tests were performed. In each of these tests, the data was parti-
tioned multiple times into training and test sets. The classifier was 
trained on the training sets, and its predictions for the test sets 
were compared to the true diagnoses. If the proportion of correct 
predictions for each group class was high, then the classifier had 
high predictive power on the data within the dataset.
resUlTs
eyetracking summary Metrics
Mean and SD performance metrics for fixation stability, pro-
saccade and smooth pursuit tasks are shown in Table 2.
Fixation Stability
Results from the fixation stability task are represented in Figure 1 
and in Table 2.
Number of Large Intrusive Saccades
Young onset Alzheimer’s disease patients made a statistically 
significant higher number of large intrusive saccades compared 
to healthy controls [YOAD: 2.5 (4.3), healthy controls: 0.7 (1.7), 
t = 2.5, p = 0.02].
Number of Square Wave Jerks
Healthy controls and YOAD patients did not show a statistically 
significant difference in terms of the average number of square 
FigUre 1 | (a) Performance of a control and a young onset Alzheimer’s disease (YOAD) patient in the fixation stability task: light blue circles show fixations, yellow 
arrows indicate saccades, and red crosses represent target position. (B) Group means for controls and YOAD patients for the different task metrics. Error bars 
represent SE.
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wave jerks [YOAD: 0.9 (1.6); healthy controls 0.9 (1.6); t = 0.4, 
p = 0.60].
Maximum Fixation Duration
The longest period of fixation was significantly shorter for 
YOAD patients as compared to healthy controls [YOAD: 1,950.7 
(1,352.8) ms; healthy controls: 2,908.5 (2,062.1) ms; t = −2.3, 
p = 0.02].
Pro-Saccade
Results from the pro-saccade task are represented in Figure 2 and 
in Table 2.
Accuracy
Young onset Alzheimer’s disease patients had an overall signifi-
cantly lower accuracy compared to healthy controls (z = −2.1, 
p =  0.04). The effect of stimulus distance was statistically sig-
nificant: the greater the distance from the center, the lower the 
accuracy (z = −3.5, p < 0.001). When looking at the accuracy 
for specific stimulus distances YOAD patients showed a trend 
toward lower accuracy than controls at 10° and 15° (z = −1.81, 
p = 0.07) but not at 5° (z = −1.64, p = 0.10). The effect of stimulus 
direction was not statistically significant when comparing the 
accuracy of YOAD patients and healthy controls (z  =  0.79, 
p = 0.40).
Time Taken to Fixate the Target
Young onset Alzheimer’s disease patients took significantly 
longer to fixate the target compared to healthy controls (t = 3.7, 
p = 0.001). The effect of the stimulus distance was significant on 
the time taken to fixate the target: the time increased with stimu-
lus distance (t = 4.2, p < 0.001). A statistical trend was observed 
for the effect of stimulus direction (t = −1.9, p = 0.06). YOAD 
patients took more time to reach the target at all stimulus dis-
tances (all p < 0.01) as well as all stimulus directions (all p < 0.01) 
compared to controls.
Number of Saccades Necessary to Fixate the Target
Young onset Alzheimer’s disease patients made a statistically 
higher number of saccades in order to fixate the target (t = 3.65, 
p  =  0.001). The effect of the stimulus distance (t  =  −3.7, 
p < 0.001) and the stimulus direction (t = 4.9, p < 0.001) both 
had a significant effect on the number of saccades necessary to 
reach the target. The number of saccades increased with stimulus 
distance and the greatest number of saccades for both groups was 
made when the stimulus moved upwards. YOAD patients made 
a greater number of saccades to reach the target for all stimulus 
distances (all p < 0.001) and stimulus directions (all p < 0.001) 
compared to controls.
Smooth Pursuit
Results from the smooth pursuit task are represented in Figure 3 
and are reported in Table 2.
Pursuit Gain
Young onset Alzheimer’s disease patients and healthy controls did 
not differ in terms of pursuit gain (t = 0.52, p = 0.60). Stimulus 
velocity did not have a statistically significant effect (t = −0.95, 
p = 0.30) but stimulus direction did (t = 4.06, p < 0.001). Pursuit 
gain was closer to one (one: eye velocity =  target velocity, eyes 
moving at the exact target’s velocity) when the target moved 
horizontally (as opposed to vertically) for both groups.
Proportion of Time Pursuing the Target
Young onset Alzheimer’s disease patients spent significantly 
less time pursing the target compared to controls (t  =  −5.5, 
p < 0.001). Stimulus direction (t = −10.31, p < 0.001) and velocity 
(t = −10.84, p < 0.001) were both statistically significant: the pro-
portion of time pursuing the target was greater when the target 
moved at 10°/s (as opposed to 20°/s) and horizontally (compared 
to vertically). YOAD patients spent less time pursuing the target 
when it was presented either horizontally (t = −4.29, p < 0.001) 
or vertically (t = −5.79, p < 0.001) as well as at both stimulus 
FigUre 3 | (a) Performance of a control and a young onset Alzheimer’s disease (YOAD) patient in the smooth pursuit task: light blue circles show fixations, yellow 
arrows indicate saccades, and red crosses represent target position. (B) Group means for controls and YOAD patients for the different task metrics. Error bars 
represent SE.
FigUre 2 | (a) Performance of a control and a patient with young onset Alzheimer’s disease (YOAD) in the pro-saccade task: light blue circles show fixations, 
yellow arrows indicate saccades, red crosses represent target position and orange circles outline the interest area (1.5° from the center of the target). (B) Group 
means for controls and YOAD patients for the different task metrics. Error bars represent standard error.
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velocities (10°/s: t = −5.02, p < 0.001, 20°/s: t = −5.59, p < 0.001) 
when compared to controls.
Comparisons between Eyetracking Metrics in tAD 
and PCA Patients
Given the aims of the present study, all the described analyses 
were conducted by examining individuals with tAD and PCA 
as part of the same group of individuals with YOAD. There were 
statistically significant differences between the two groups of 
patients in only three out of the eight eyetracking metrics all 
of which showed a poorer performance of PCA compared to 
tAD: maximum fixation duration (controls: 2,908.5  ms, tAD: 
2,183.6 ms, PCA: 1,342.4 ms, t = 2.85, p = 0.006); time to fixate 
the target (controls: 328.7 ms, tAD: 428.4 ms, PCA: 924.4 ms, 
t = 5.13, p < 0.001) and number of saccades necessary to reach 
the target (controls  =  2.13, tAD:2.59, PCA: 4.86, t  =  5.13, 
p <  0.001). PCA and tAD individual group performance was 
worse than that of healthy controls on all metrics for the three 
tasks (all p < 0.001).
No statistically significant differences were observed between 
tAD and PCA in the remaining five-eyetracking metrics. There 
was no difference in the number of square wave jerks (controls: 
0.93, tAD: 1.04, PCA: 0.82, t =  0.11, p =  0.91) or pursuit gain 
(controls: 1.36, tAD: 1.35, PCA: 1.62, t = 1.50, p = 0.14) between 
TaBle 3 | Spearman’s rank coefficient (Spearman’s rho) and p values for correlations between visual cognitive tests and eyetracking metrics for the fixation stability, 
pro-saccade and smooth pursuit tasks.
eyetracking metrics
Fixation stability Pro-saccade smooth pursuit
no. of large 
intrusive 
saccades
no. of 
square 
wave jerks
Max. fixation 
duration (ms)
accuracy Time to 
reach the 
target (ms)
saccades 
made to fixate 
the target
Pursuit gain Prop. of time 
pursuing the 
target
V
is
ua
l C
og
ni
tiv
e 
Te
st
VOSP shape detection r = −0.16 r = 0.04 r = 0.19 r = −0.26 r = −0.19 r = −0.38 r = −0.09 r = 0.04
p = 0.38 p = 0.81 p = 0.28 p = 0.14 p = 0.71 p = 0.03* p = 0.61 p = 0.81
VOSP object decision r = −0.49 r = −0.32 r = 0.26 r = 0.09 r = −0.44 r = −0.64 r = −0.39 r = 0.29
p = 0.003* p = 0.06 p = 0.13 p = 0.61 p = 0.009* p < 0.001* p = 0.03* p = 0.11
VOSP fragmented letters r = −0.41 r = −0.16 r = 0.26 r = 0.14 r = −0.40 r = −0.61 r = −0.23 r = 0.41
p = 0.02* p = 0.36 p = 0.14 p = 0.44 p = 0.02* p < 0.001* p = 0.22 p = 0.02*
VOSP dot counting r = −0.48 r = 0.07 r = 0.32 r = 0.18 r = −0.60 r = −0.54 r = −0.46 r = 0.66
p = 0.005* p = 0.70 p = 0.07 p = 0.32 p = 0.002* p < 0.001* p = 0.01* p < 0.001*
A cancelation time r = 0.29 r = −0.15 r = −0.10 r = −0.04 r = 0.32 r = 0.45 r = 0.25 r = −0.49
p = 0.10 p = 0.42 p = 0.57 p = 0.79 p = 0.07 p = 0.009* p = 0.19 p = 0.006*
National adult reading test r = −0.23 r = −0.06 r = 0.14 r = 0.08 r = 0.18 r = −0.08 r = −0.14 r = 0.03
p = 0.18 p = 0.72 p = 0.44 p = 0.64 p = 0.32 p = 0.66 p = 0.48 p = 0.88
Statistically significant correlations are highlighted in blue and their p values marked with an asterisk (*).
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tAD and PCA nor was there an effect of the phenotype in general 
(t = 0.36, p = 0.72 and t = 1.50, p = 0.14, respectively). No dif-
ferences were observed between tAD and PCA in the number 
large intrusive saccades (controls: 0.67, tAD: 1.81, PCA: 4.39, 
t = −1.56, p = 0.12) and accuracy in the pro-saccade task (con-
trols: 0.94, tAD: 0.89, PCA: 0.75, z = 1.55, p = 0.12). For these 
two metrics patients performed worse than controls but only 
PCA were statistically worse (t = 2.38, p = 0.02 and z = −2.62, 
p = 0.01, respectively). No difference was observed between the 
two groups of patients in the proportion of time pursuing the 
target (controls: 0.58, tAD: 0.40, PCA: 0.34, t = 1.11, p = 0.27) 
and the two performed statistically worse compared to controls 
(both p < 0.001).
relationship between Oculomotor Metrics 
and standard Visual cognitive Tests
In Table  3 coefficients and p values of correlations between 
estimates of visual cognitive processing and eyetracking metrics 
for the fixation stability, pro-saccade and smooth pursuit tasks 
are reported.
Fixation Stability
Statistically significant negative correlations were observed 
between the number of large intrusive saccades and the scores on 
the following visual cognitive tests: object decision, fragmented 
letter, and dot counting. The association between the number 
of square wave jerks and the score in the object decision test 
approached statistical significance (p = 0.06) as did the associa-
tion between maximum fixation duration and dot-counting task 
(p = 0.07) (see Figure 4).
Pro-Saccade
Statistically significant negative correlations were reported 
between the time taken to fixate the target and the following 
visual cognitive tests: object decision, fragmented letters, and dot 
counting. The association between the time taken to fixate the 
target and the scores corresponding to the “A” cancelation task 
approached statistical significance (p = 0.07).
Statistically significant negative correlations were found 
between the number of saccades necessary to fixate the target 
and the shape detection, object decision, fragmented letters, and 
dot-counting tests as well as a positive correlation with the “A” 
cancelation test scores (see Figure 5).
Smooth Pursuit
Statistically significant correlations were observed between visual 
cognitive scores and both the pursuit gain and the proportion 
of time spent pursuing the target during the trial. In particular, 
the pursuit gain scores for YOAD patients negatively correlated 
with the object decision and dot-counting tests. The proportion 
of time spent pursuing the target positively correlated with the 
fragmented letters, dot counting and negatively with the “A” 
cancelation test scores (see Figure 6).
Machine-learning classification Model
Fitting the HMM to each trial of the smooth pursuit experiment 
resulted in fitted parameters that conformed to expectations. In 
particular, the fitted model placed significantly more likelihood 
on the movement directions that followed the target than on any 
other direction. The results of the logistic regression classifier 
using the automatically generated feature vectors were able to 
discriminate with 95% accuracy patients and controls. Feature 
FigUre 4 | Scatter plots showing correlations between fixation stability metrics and visual cognitive scores for young onset Alzheimer’s disease patients. 
Statistically significant correlations are marked with a blue background and statistical trends (p > 0.05 and p < 0.10) in a lighter blue. Best fit line and 95% CI are 
shown. Each data point corresponds to a participant and its size is proportionate to the Mini-Mental State Examination score (indication of disease severity). typical 
AD (tAD) patients are shown in blue and posterior cortical atrophy (PCA) in green.
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FigUre 5 | Scatter plots showing correlations between pro-saccade metrics and visual cognitive scores for young onset Alzheimer’s disease patients. Statistically 
significant correlations are marked with a blue background and statistical trends (p > 0.05 and p < 0.10) in a lighter blue. Best fit line and 95% CI are shown. Each 
data point corresponds to a participant and its size is proportionate to the Mini-Mental State Examination score (disease severity). typical AD (tAD) individuals are 
shown in blue and posterior cortical atrophy (PCA) in green.
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FigUre 6 | Scatter plots showing correlations between smooth pursuit metrics and visual cognitive scores for young onset Alzheimer’s disease patients. 
Statistically significant correlations are marked with a blue background and statistical trends (p > 0.05 and p < 0.10) in a lighter blue. Best fit line and 95% CI are 
shown. Each data point corresponds to a participant and its size is proportionate to the Mini-Mental State Examination score (disease severity). typical AD (tAD) 
individuals are shown in blue and posterior cortical atrophy (PCA) in green.
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TaBle 4 | Table showing the results of cross-validation tests for the predictive 
power of the Bayesian logistic regression classifier.
Test actual diagnosis Predicted diagnosis
control Young onset alzheimer’s disease 
(YOaD) patient
L-1-O Control 0.95 0.05
YOAD patient 0.03 0.97
L-2-O Control 0.95 0.05
YOAD patient 0.03 0.97
L-H-O Control 0.94 0.06
YOAD patient 0.04 0.96
Leave-one-out (L-1-O) tests take each individual in turn and train the classifier on all 
other individuals’ feature vectors. The diagnostic status of that individual is predicted by 
the classifier and compared to the actual diagnosis (YOAD patient vs. control). Leave-
two-out (L-2-O) tests take each possible pair of one control individual and one patient, 
train on all other individuals, and then predict the diagnosis of the original pair. The 
leave-half-out (L-H-O) test takes 500 random partitions of the data, with half of each 
diagnostic class in each partition, trains on one partition and predicts the diagnoses 
of the other. The columns of the table represent predicted diagnostic classes, and the 
rows represent actual diagnoses.
13
Pavisic et al. Eyetracking Metrics in Dementia
Frontiers in Neurology | www.frontiersin.org August 2017 | Volume 8 | Article 377
vectors generated as described above are effective at separating 
the patients in the dataset into their diagnostic classes. The 
results of each test for the experiment are shown in Table 4. As 
can be seen, the predicted diagnoses show at least 95% accuracy 
for both diagnostic classes (patients vs. controls). While these 
results are very promising, they do only relate to the data from 
a relatively small number of individuals on a single test. An 
expanded experimental set-up, with a larger sample size, would 
be able to further verify the utility of this methodology for accu-
rately predicting the diagnoses of previously unseen individuals.
DiscUssiOn
In the present study, we examined basic oculomotor metrics 
in individuals with YOAD and explored the link between such 
metrics and measures of visual cognition.
Results confirmed that patients have abnormal eye movement 
patterns in fixation stability, saccade and smooth pursuit tasks as 
compared to age-matched healthy controls. In the fixation stabil-
ity task, YOAD patients showed a larger number of large intrusive 
saccades and shorter fixation duration. In the pro-saccade task, 
they were less accurate, required a longer amount of time and 
greater saccadic movements to fixate the target. Finally, in the 
smooth pursuit task, YOAD patients spent a shorter amount of 
time pursuing the target and made more interruptive saccades 
compared to controls. Results also demonstrated that these estab-
lished basic control and movement metrics were significantly 
associated with measures of higher order visual cognition. In 
the fixation stability task the number of large intrusive saccades 
negatively correlated with performance in the object decision, 
fragmented letters and dot-counting tests. Pro-saccade metrics 
such as the time taken to reach the target and the number of 
saccades made in the process negatively correlated with object 
decision, fragmented letters, and dot-counting test scores. 
Additionally the “number of saccades necessary to reach the 
target” also correlated with shape detection scores and as the 
time taken to complete the “A” cancelation task. The eyetracking 
metrics extracted from the smooth pursuit task correlated with 
object decision, fragmented letters, dot counting and time to 
complete the “A” cancelation tests.
To our knowledge, this is the first time that the systematic 
impairment of basic oculomotor functions is reported in patients 
with young onset dementia as a single group and that the relation-
ship between such impairment and visual cognition is explored.
Our data underline the extent of visual cognitive impairments 
in individuals with YOAD (18). Awareness of dementia-related 
visual dysfunction in tAD is increasing (11, 12, 55) but, especially 
in the early stages of the disease, sensitive measures are required 
in order to highlight subtle changes that can potentially be 
discriminated from normal aging. For example, a recent study 
has shown that an eyetracking behavioral task can predict the 
conversion from cognitively normal to MCI and from MCI to 
AD up to three years prior to a change in clinical diagnosis (56). 
The presence of both eye movement deficits and impairments 
in visual processing is in accordance with the neuroimaging 
and neuropathological literature showing that in AD multi-
focal neuronal degeneration affects visual areas in the occipital, 
temporal and parietal lobes (57–59) and subcortical regions such 
as pulvinar (60) that process visual information and orient eye 
movements accordingly (61, 62).
The present study provides preliminary evidence suggesting 
the potential use of eyetracking metrics as markers of high-level 
vision and other cognitive domains. Examining the pattern of 
correlations, it should be noted that some eyetracking metrics, 
especially the “number of saccades needed to fixate the target,” 
correlated with most of the visual cognitive tests, possibly reflect-
ing non-specific associations with disease severity or the ubiquity 
of pro-saccade generation deficits in YOAD patients. However, 
not all eyetracking metrics had such widespread associations. 
Particularly evident were the impact of “large intrusive saccades” 
and “time to reach a pro-saccade target” upon the visuoperceptual 
tests (object decision and fragmented letters) and the visuospatial 
dot-counting test. All three of these tests require scanning over 
relatively small visual areas and across multiple discrete perceptual 
items, all of which are relevant to the task demands. By contrast, 
neither of these eyetracking metrics was correlated significantly 
with the “A” cancelation test, in which visual attention must be 
deployed over a much wider visual area and across items, only a 
small proportion of which constitute task-relevant targets. Also 
possibly noteworthy are the significant correlations between the 
“proportion of time pursuing target” metric from the smooth 
pursuit task and the fragmented letter, dot counting and “A” 
cancelation tests. Unlike the other tests with which these correla-
tions were not observed, these three tests all require participants 
to trace a specific continuous visual route through separated 
stimuli, whether that route pertains to the shape of a large letter 
(fragmented letter), the path through a group of dots that permits 
them to be counted (and not accidentally re-counted) in an effi-
cient manner (dot counting), or the line-by-line orderly searching 
for target “A”s among other distractor letters (A cancelation).
Of equal note is the relative absence of correlations between 
eyetracking metrics and either shape detection or reading. In 
the case of shape detection, which was only correlated with the 
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number of saccades required to reach the pro-saccade target, this 
may relate in part to the limited dynamic range of the test (all 
patient scores between 15 and 20 out of 20). However, for single 
word reading, with which there were no significant correlations 
and which with small print can be achieved in a single fixation, 
disordered eye movements such as large saccadic intrusions 
appear to have relatively little impact on accuracy (though note 
that reading latencies, if recorded, may have elicited a different 
result).
Naturally, such a qualitative examination of patterns of asso-
ciation has inherent limitations in determining causal relations 
between cognitive functions and observed behaviors. However, 
the current data arguably provide a useful starting point for 
generating testable hypotheses regarding the ability of certain 
eye movement patterns and paradigms to index specific cognitive 
abilities and deficits among dementia patients and other clinical 
populations.
Eyetracking-based measures of cognition may offer certain 
advantages over traditional pen and paper-based cognitive tests 
in some dementia contexts. Eyetracking data by definition do not 
suffer from ceiling and floor effects, which are instead common 
problems when exploring cognitive performance in patients 
(floor effect) and comparing it with performance in age-matched 
healthy controls (ceiling effect). Tasks such a fixation stability, 
saccade generation and smooth pursuit require minimal verbal 
instructions. Eye movement metrics derived from appropriate 
test designs may also be less vulnerable to the practice effects 
normally observed in standard cognitive testing, allowing for 
re-testing in the context of longitudinal assessments or before/
after a trial phase.
One further potential advantage of eyetracking-based meas-
ures of visual cognition and other cognitive capacities is the 
type and scale of data generated. The large datasets that can be 
extracted in terms of time series of x and y coordinates open up 
new avenues of statistical analysis on individual trials. This may 
contribute to the design of shorter, less stressful cognitive assess-
ments for patients. In the current study, we have provided proof 
of principle evidence for the feasibility of using an eyetracking 
dataset as the input for a machine-learning classification model 
to discriminate YOAD patients and controls on the basis of eye 
movements alone. While eyetracking in isolation is unlikely to 
ever be a primary determinant of clinical decision making, the 
application of a machine-learning approach to such examinations 
may add value in detecting change in at risk and presymptomatic 
individuals, monitoring progression over time (especially in 
the context of clinical trials), improving the discrimination and 
characterization disease and syndromic phenotypes.
The study had a number of potential limitations. First, the 
sample size was relatively small, and thus we have not been 
able to clarify whether the eye movement impairment is more 
widely a consequence of the disease severity rather than being 
a direct indication of visual cognition. Nonetheless, previous 
studies exploring eyetracking metrics in individuals affected 
by different types of dementia but matched for disease severity 
have shown that eye movement deficits can be disease-specific 
(33, 63). Second, the study did not include markers of focal and 
sustained attention, deficits in which may have contributed to 
both eyetracking metrics and visual cognition estimates. Third, 
we only found limited evidence of differences between PCA 
and tAD in terms of eyetracking metrics. This result can have 
several explanations. The PCA group size was very small and 
the individual variability within each group was very large, as is 
frequently described within this literature (28, 64, 65). This might 
reflect the biological reality of YOAD where a greater prevalence 
of visual deficits across the population has already been suggested 
(18) and/or the phenotypic continuum of visual impairment 
across the tAD-PCA spectrum (64, 66). To address further the 
issue of individual phenotypic differences, rather than a binary 
PCA/tAD diagnostic category, future studies involving a larger 
sample size should take into account the possibility of using a 
quantitative continuous metric of visual cognitive impairment, 
such as a ratio of memory to perceptual and/or spatial scores.
In conclusion, we have demonstrated that basic oculomotor 
metrics can provide information about not only the oculomo-
tor system and its functionality per se, but also about high-level 
visual cognition. We have also shown that such metrics can be 
used in a machine-learning approach to discriminate between 
YOAD patients and healthy controls. Visual deficits represent 
a common feature in AD and eyetracking metrics may have 
potential as sensitive markers, particularly as outcome measures 
for clinical trials.
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